Cell confinement by micropatterning induces phenotypic changes in cancer-associated fibroblasts
Source abstract
Abstract
Recent advances in single-cell studies have revealed the vast transcriptomic heterogeneity of cancer-associated fibroblasts (CAFs), with each subset likely having unique roles in the tumor microenvironment. However, it is still unclear how different CAF subsets should be cultured in vitro to recapitulate their in vivo phenotype. The inherent plasticity of CAFs, or their ability to dynamically change their phenotype in response to different environmental stimuli, makes it highly challenging to induce and maintain a specific CAF state in vitro. In this study, we investigated how cell shape and confinement on two-dimensional culture substrates with different stiffnesses influence CAF transcriptomic profile and phenotype. Using micropatterning of polyacrylamide hydrogels to induce shape- and confinement-dependent changes in cell morphology, we observed that micropatterned CAFs exhibited phenotypic shifts towards more desmoplastic and inflammatory CAF subsets. Additionally, micropatterning enabled control over a range of CAF-specific markers and pathways. Lastly, we report how micropatterned and non-micropatterned CAFs respond differently to anti-cancer drugs, highlighting the importance of phenotype-oriented therapy that considers for CAF plasticity and regulatory networks. Control over CAF morphology offers a unique opportunity to establish highly robust CAF phenotypes in vitro, facilitating deeper understanding of CAF plasticity, heterogeneity, and development of novel therapeutic targets. STATEMENT OF SIGNIFICANCE: Cancer-associated fibroblasts (CAFs) are the dominant stromal cell type in many cancers, and recent studies have revealed that they are highly heterogeneous and comprise several subpopulations. It is still unclear how different subsets of CAFs should be cultured in vitro to recapitulate their in vivo phenotype. In this study, we investigated how cell shape and confinement affect CAF transcriptomic profile and phenotype. We report that micropatterned CAFs resemble desmoplastic and inflammatory CAF subsets observed in vivo and respond differently to anti-cancer drugs as compared to non-patterned CAFs. Control over CAF morphology enables the generation of highly robust CAF phenotypes in vitro, facilitating deeper understanding of CAF plasticity and heterogeneity.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Cells and Metastasis · Cellular Mechanics and Interactions · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets10.3390/cancers14051231 ↗
2. Cancer-associated fibroblasts: master tumor microenvironment modifiers10.3390/cancers15061899 ↗
3. Cancer-associated fibroblasts and their role in tumor progression
4. Transcription factors in fibroblast plasticity and CAF heterogeneity10.1186/s13046-023-02934-4 ↗
5. Cancer-associated fibroblast heterogeneity and its influence on the extracellular matrix and the tumor microenvironment10.3390/ijms241713482 ↗
6. Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer
7. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer10.1084/jem.20162024 ↗
8. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials10.1186/s12943-023-01860-5 ↗
9. Role of tumor microenvironment in cancer progression and therapeutic strategy10.1002/cam4.5698 ↗
10. Mechanoregulation of cancer-associated fibroblast phenotype in three-dimensional interpenetrating hydrogel networks10.1021/acs.langmuir.8b02649 ↗
11. Bioengineered hydrogels recapitulate fibroblast heterogeneity in cancer10.1002/advs.202307129 ↗
12. 3D cell culture systems: tumor application, advantages, and disadvantages10.3390/ijms222212200 ↗
13. Cell culture model evolution and its impact on improving therapy efficiency in lung cancer10.3390/cancers15204996 ↗
14. Engineered microenvironment for the study of myofibroblast mechanobiology10.1111/wrr.12955 ↗
15. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction10.1165/rcmb.2012-0050OC ↗
16. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy10.1186/s13045-019-0770-1 ↗
17. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy10.1007/s10555-024-10186-7 ↗
18. Cancer cell culture: the basics and two-dimensional cultures10.1007/978-1-0716-3056-3_1 ↗
19. Multivariate analysis reveals activation-primed fibroblast geometric states in engineered 3D tumor microenvironments10.1091/mbc.E19-08-0420 ↗
20. Bio-inspired micropatterned hydrogel to direct and deconstruct hierarchical processing of geometry-force signals by human mesenchymal stem cells during smooth muscle cell differentiation10.1038/am.2015.66 ↗
21. Geometric cues for directing the differentiation of mesenchymal stem cells10.1073/pnas.0903269107 ↗
22. Patterned hydrogels for simplified measurement of cell traction forces10.1016/B978-0-12-800281-0.00002-6 ↗
23. J.R. Tse, A.J. Engler, Preparation of hydrogel substrates with tunable mechanical properties, Curr. Protoc. Cell Biol. 47 (2010), p. 2, doi:10.1002/0471143030.cb1016s47.10.1002/0471143030.cb1016s47 ↗
24. A tense situation: Forcing tumour progression10.1038/nrc2544 ↗
25. Tumor matrix stiffness provides fertile soil for cancer stem cells10.1186/s12935-023-02992-w ↗
26. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment10.1016/j.biomaterials.2022.121527 ↗
27. pyComBat, a Python tool for batch effects correction in high-throughput molecular data using empirical Bayes methods10.1186/s12859-023-05578-5 ↗
28. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq210.1186/s13059-014-0550-8 ↗
29. Salmon provides fast and bias-aware quantification of transcript expression10.1038/nmeth.4197 ↗
30. A bi-symmetric log transformation for wide-range data10.1088/0957-0233/24/2/027001 ↗
31. Z. Fang, X. Liu, G. Peltz, GSEApy: a comprehensive package for performing gene set enrichment analysis in Python, Bioinformatics 39 (2023) 2, doi:10.1093/bioinformatics/btac757.10.1093/bioinformatics/btac757 ↗
32. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles10.1073/pnas.0506580102 ↗
33. Advances in micropatterning technology for mechanotransduction research10.1016/j.mbm.2024.100066 ↗
34. Cell distribution of stress fibres in response to the geometry of the adhesive environment10.1002/cm.20126 ↗
35. Spatial coordination between cell and nuclear shape within micropatterned endothelial cells10.1038/ncomms1668 ↗
36. Dimensionality and spreading influence MSC YAP/TAZ signaling in hydrogel environments10.1016/j.biomaterials.2016.06.061 ↗
37. YAP regulates cell mechanics by controlling focal adhesion assembly10.1038/ncomms15321 ↗
38. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives10.1002/cac2.12392 ↗
39. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment10.1038/s41388-019-0765-y ↗
40. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment10.1016/j.semcancer.2021.03.006 ↗
41. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance10.1158/1078-0432.CCR-20-4226 ↗
42. Cancer-associated fibroblast subpopulations with diverse and dynamic roles in the tumor microenvironment10.1158/1541-7786.MCR-21-0282 ↗
43. The hippo pathway: a master regulatory network important in cancer10.3390/cells10061416 ↗
44. The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts, Signal Transduct
45. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics10.1101/gad.304501.117 ↗
46. Reciprocal crosstalk between YAP1/Hippo pathway and the p53 family proteins: mechanisms and outcomes in cancer10.3389/fcell.2019.00159 ↗
47. Mutant p53 protein and the hippo transducers YAP and TAZ: a critical oncogenic node in human cancers10.3390/ijms18050961 ↗
48. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts10.1038/s41467-018-07987-0 ↗
49. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
50. What is new in cancer-associated fibroblast biomarkers?10.1186/s12964-023-01125-0 ↗
51. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/β-catenin pathway10.1186/s12885-018-5035-9 ↗
52. L. Xin, J. Gao, Z. Zheng, Y. Chen, S. Lv, Z. Zhao, C. Yu, X. Yang, R. Zhang, Fibroblast activation protein-α as a target in the bench-to-bedside diagnosis and treatment of tumors: a narrative review, Front. Oncol. 11 (2021), p. 3, doi:10.3389/fonc.2021.648187.10.3389/fonc.2021.648187 ↗
53. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects10.1002/stem.1251 ↗
54. Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-β110.1002/stem.2412 ↗
55. MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
56. Teaming up for trouble: cancer cells, transforming growth factor-β1 signaling and the epigenetic corruption of stromal naïve fibroblasts10.3390/cancers10030061 ↗
57. Il1-induced Jak/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma10.1158/2159-8290.CD-18-0710 ↗
58. Biomarkers for epithelial-mesenchymal transitions10.1172/JCI36183 ↗
59. A wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer10.1158/0008-5472.CAN-20-0263 ↗
60. Twist1 is a key regulator of cancer-associated fibroblasts10.1158/0008-5472.CAN-14-0350 ↗
61. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis10.1016/j.ccell.2019.08.003 ↗
62. Deadly crosstalk: notch signaling at the intersection of EMT and cancer stem cells10.1016/j.canlet.2013.08.027 ↗
63. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer10.1016/j.ygyno.2020.11.026 ↗
64. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma10.1002/path.4467 ↗
65. TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis
66. Stromal expression of vimentin predicts the clinical outcome of stage II colorectal cancer for high-risk patients10.12659/MSM.904486 ↗
67. Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway
68. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts10.1186/s13046-018-0965-2 ↗
69. Exosomes released by gastric cancer cells induce transition of pericytes into cancer- associated fibroblasts10.12659/MSM.906641 ↗
70. The emerging mechanisms of isoform-specific PI3K signalling10.1038/nrm2882 ↗
71. The PI3K pathway as drug target in human cancer10.1200/JCO.2009.25.3641 ↗
72. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation10.1016/j.tibs.2011.03.006 ↗
73. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation10.1016/j.cub.2008.07.078 ↗
74. Regulation and metabolic functions of mTORC1 and mTORC210.1152/physrev.00026.2020 ↗
75. Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway10.1038/s41368-021-00115-7 ↗
76. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling10.1016/j.canlet.2018.10.015 ↗
77. The transformation of cancer-associated fibroblasts: current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance10.1016/j.canlet.2021.08.002 ↗
78. Smad-dependent and Smad-independent pathways in TGF-β family signalling10.1038/nature02006 ↗
79. TGF-β signaling in health, disease, and therapeutics10.1038/s41392-024-01764-w ↗
80. Advances in regulating cellular behavior using micropatterns10.59249/UXOH1740 ↗
81. Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma10.1371/journal.pone.0006879 ↗
82. Nemosis, a novel way of fibroblast activation, in inflammation and cancer10.1016/j.yexcr.2009.03.005 ↗
83. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells10.1158/0008-5472.CAN-11-3132 ↗
84. Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia10.1038/s41598-024-52020-8 ↗
85. PTEN Loss promotes MAPK pathway dependency in HER2/neu breast carcinomas10.1073/pnas.1523693113 ↗
86. Periostin, a signal transduction intermediate in TGF-β-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins10.18632/oncotarget.25153 ↗
87. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
88. Suppression of feedback loops mediated by pi3k/mtor induces multiple overactivation of compensatory pathways: An unintended consequence leading to drug resistance10.1158/1535-7163.MCT-14-0330 ↗
89. Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
90. Transforming growth factor-beta (TGF-β) signaling in cancer-A betrayal within10.3389/fphar.2022.791272 ↗
91. Exploiting the STAT3 nexus in cancer-associated fibroblasts to improve cancer therapy10.3389/fimmu.2021.767939 ↗
92. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
93. Clinical and therapeutic relevance of cancer-associated fibroblasts10.1038/s41571-021-00546-5 ↗
94. S. Poon, L.E. Ailles, Modeling the role of cancer-associated fibroblasts in tumor cell invasion, Cancers (Basel) 14 (2022), pp. 3, 7, 9, 12, 15, doi:10.3390/cancers14040962.10.3390/cancers14040962 ↗
95. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform10.3389/fbioe.2016.00012 ↗
96. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures
97. 3D micropattern force regulates stem cell function10.1093/nsr/nwad198 ↗
98. Diversity and biology of cancerassociated fibroblasts10.1152/physrev.00048.2019 ↗
99. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts10.1158/2159-8290.CD-19-0094 ↗
100. Phenotypic plasticity of fibroblasts during mammary carcinoma development10.3390/ijms20184438 ↗